42 new facilities in next three quarters
Management targets launching 42 new facilities across India, with 23 in the south, 9 in the west, 5 in the north, and 5 in the east.
AGARWALEYE / guidance tracker
Keep management guidance in view.
Dr. Agarwal's Health Care · forward-looking guidance across the available source record.
Research layer active
Guidance tracker
What management said would happen.
expansion
FY26 capex of ₹310 crore
Capex guidance for FY26 remains unchanged at ₹310 crore, supporting the expansion plan.
ROIC improvement of 1-1.5% in FY26
Management expects ROIC to increase by about 1 to 1.5 percentage points in FY26 from ~16% in FY25.
Merger of subsidiary within 1-1.5 years
Management aims to complete the merger of the listed subsidiary with the parent within the next 1 to 1.5 years, with more clarity in coming weeks.
FY27 facility expansion target of 60 new facilities (40 surgical)
Q1 delivered 18 facilities (16 surgical) setting rapid pace. Q2 targets 12 facilities with 30 in H2. Pipeline of 30+ signed LOIs provides visibility.
Merger completion expected by mid-November
Final closing items are in progress for the merger, expected to conclude around mid-November.
Sustained growth momentum through deeper micro-market penetration and new geographies
Management expects to continue growth driven by existing facility ramp-up, new market entry, and accelerated adoption of innovative surgical procedures.
SSG target of 12-13% for mature markets considered phenomenal performance
While 16.3% SSSG delivered in Q1 for FY23-and-earlier cohort, management views 12-13% as sustainable long-term same-store growth for mature facilities.
Annual facility additions of 55-60
Management guided to add 55-60 new facilities every year, increasing network size by ~20% annually.
Q4 FY26 facility additions: 16 centers
Plan to launch 16 new centers in Q4 FY26, including 11 surgical centers across south, west, and north regions.
Capex guidance of ₹310 crore for FY26
Management committed ₹310 crore capex for FY26; ₹275 crore already spent in 9M FY26.
Merger completion by Q3-Q4 FY27
The merger process with subsidiaries is expected to be completed by Q3 or Q4 of FY27, pending regulatory approvals.